Third Party Personnel. If Party has engaged the services of a caterer, musicians, or other third parties that will make deliveries, or otherwise need access to the facilities prior to 1 hour before the start time for the event, the names & contact information of all such persons or companies must be provided to the Church in advance together with time access to building is needed. Note: On-site caterer must provide proof of insurance effective during event.
Third Party Personnel. Within 120 days after the Effective Date and annually thereafter by the anniversary of the Effective Date, GSK shall send a letter to each entity employing Third Party Personnel. The letter shall describe GSK’s obligations under the CIA and its commitment to full compliance with all Federal health care program requirements and FDA requirements. The letter shall include a description of GSK’s Compliance Program. GSK shall attach a copy of its Code of Conduct to the letter and shall request the entity employing Third Party Personnel to either: (a) make a copy of GSK’s Code of Conduct and a description of GSK’s Compliance Program available to its employees who meet the definition of Third Party Personnel as set forth in Section II.C.9; or (b) represent to GSK that it has and enforces a substantially comparable set of code of conduct and Compliance Program for its employees who meet the definition of Third Party Personnel as set forth in Section II.C.9.
Third Party Personnel. Within 120 days after the Effective Date, and annually thereafter by the anniversary of the Effective Date, Forest shall send a letter to each entity employing Third Party Personnel. The letter shall outline Forest’s obligations under the CIA and its commitment to full compliance with all Federal health care program and FDA requirements. The letter shall include a description of
Third Party Personnel. Within 90 days after the Effective Date, and annually thereafter by the anniversary of the Effective Date, Indivior shall send, electronically or in hard copy format, a letter to each entity employing Third Party Personnel. The letter shall outline Indivior’s obligations under the CIA and its commitment to full compliance with all Federal health care program and FDA requirements. The letter shall include a description of Indivior’s Compliance Program. Indivior shall include with the letter a copy of its Code of Conduct and shall request the entity employing Third Party Personnel to either: (a) make a description of Indivior’s Compliance Program available to its Third Party Personnel; or (b) represent to Indivior that it has and enforces a substantively comparable compliance program for its Third Party Personnel.
Third Party Personnel. Within 90 days after the Effective Date, and annually thereafter by the anniversary of the Effective Date, Indivior shall send, electronically or in hard copy format, a letter to each entity employing Third Party Personnel. The letter shall outline Indivior’s obligations under the CIA and its commitment to full compliance with all Federal health care program and FDA requirements. The letter shall include a description of
Third Party Personnel. Within 120 days after the Effective Date, and annually thereafter by the anniversary of the Effective Date, AstraZeneca and/or the AstraZeneca Affiliate shall send a letter to each entity employing Third Party Personnel to the extent that the activities of the Third Party Personnel are governed by Federal health care and/or FDA requirements. The letter shall outline AstraZeneca’s obligations under the CIA and its commitment to full compliance with all Federal health care program and FDA requirements. The letter shall include a description of AstraZeneca’s U.S. Compliance Program. AstraZeneca and/or the AstraZeneca Affiliate shall attach a copy of its Code of Conduct to the letter and shall request the entity employing Third Party Personnel to either: (a) make a copy of AstraZeneca’s Code of Conduct and a description of AstraZeneca’s U.S. Compliance Program available to its Third Party Personnel; or (b) represent to AstraZeneca and/or the AstraZeneca Affiliate that it has and enforces a substantially comparable code of conduct and compliance program for its Third Party Personnel.
Third Party Personnel. To the extent not already accomplished, within 120 days after the Effective Date, and annually thereafter by the anniversary of the Effective Date, J&J or a J&J Pharmaceutical Affiliate shall send, electronically or in hard copy format, a letter to each entity employing Third Party Personnel. The letter shall outline obligations under the CIA and J&J and the J&J Pharmaceutical Affiliates’ commitment to full compliance with all Federal health care program and FDA requirements. The letter shall include a description of the Compliance Program. J&J or the J&J Pharmaceutical Affiliate shall include with the letter a copy of the Code of Conduct and shall request the entity employing Third Party Personnel to either: (a) make a copy of the Code of Conduct and a description of the Compliance Program available to its Third Party Personnel; or (b) represent to J&J or the J&J Pharmaceutical Affiliate that it has and enforces a substantively comparable code of conduct and compliance program for its Third Party Personnel.
Third Party Personnel. Within 90 days after the Effective Date, and annually thereafter by the anniversary of the Effective Date, Jazz shall send a letter, either in hard copy or electronic form, to each entity employing Third Party Personnel. The letter shall outline Jazz’s obligations under the CIA and its commitment to full compliance with all Federal health care program requirements. The letter shall include a description of the Jazz Compliance Program. Jazz shall attach or otherwise make available a copy of its Code of Conduct to the letter and shall request the entity employing Third Party Personnel to either: (a) make Jazz’s Code of Conduct and a description of the Jazz Compliance Program available to its Third Party Personnel; or
Third Party Personnel. Within 120 days after the Effective Date, and annually thereafter by the anniversary of the Effective Date, Novartis shall send, electronically or in hard copy format, a letter to each entity employing Third Party Personnel. The letter shall outline Novartis’ obligations under the CIA and its commitment to full compliance with all Federal health care program and FDA requirements. The letter shall include a description of Novartis’ Compliance Program. Novartis shall include with the letter a copy of its Code of Conduct and shall request the entity employing Third Party Personnel to either: (a) make a description of Novartis’ Compliance Program available to its Third Party Personnel; or (b) represent to Novartis that it has and enforces a substantively comparable compliance program for its Third Party Personnel.
Third Party Personnel. Within 90 days after the Effective Date, and annually thereafter by the anniversary of the Effective Date, Daiichi shall send, electronically or in hard copy format, a letter to each entity employing Third Party Personnel. The letter shall outline Daiichi’s obligations under the CIA and its commitment to full compliance with all Federal health care program and FDA requirements. The letter shall include a description of
